ENDRA Life Sciences Reports Second Quarter 2022 Financial Results and Provides Business Update

Go back to ENDRA Life Sciences Reports Second Quarter 2022 Financial Results and Provides Business Update
(NASDAQ: NDRA) Delayed: 6.31 --0 (-0%)
Previous Close $6.31    52 Week High
Open $6.31    52 Week Low
Day High $6.31    P/E N/A 
Day Low $6.31    EPS
Volume 108